Controlled Substances Quiz, NU 578 Unit 2 Questions and 100%Correct Answers.

Controlled Substances Quiz, NU 578 Unit 2 Questions and 100%Correct Answers. Codeine - ANSWER abused prescription drug, second-most Comprehensive Drug Abuse Prevention and Control Act - ANSWER Act also known as the Controlled Substance Act (1970) transmuscosal fentanyl only approved for breakthrough cancer pain in opioid tolerant patients - ANSWER actiq dopamine reward circuit - ANSWER addictive drugs all activate the brain's _________ naltrexone - ANSWER after detox, an opioid addict can be rx'd ___________ to discourage renewed opioid abuse for appetite stim - ANSWER AIDS patients use Dronabinol (marinol) used for tx of opioid-induced ileus - ANSWER alvimopan II - ANSWER amphetamines are schedule norepinephrine; dopamine - ANSWER amphetamines work primarily by promoting neuronal release of _________ & ___________, and partly by blocking their reuptake insomnia; weight loss - ANSWER amphetamines, most common adverse effects opioids - ANSWER analgesics, most effective available Controlled Substances Quiz, NU 578 Unit 2 Questions and 100%Correct Answers extended release morphine - ANSWER avinza none, just supportive treatment - ANSWER barbiturate OD antidote? opioid OD - ANSWER barbiturate OD produces same classic triad of symptoms (resp. depression, coma, pinpoint pupils) as seen with opioids - ANSWER barbiturate tolerant individuals are cross-tolerant to other CNS depressants (alcohol, benzos, general anesthetics) but not with ________ addiction - ANSWER behavior pattern characterized by continued use of a psychoactive substance despite physical, psychologic, or social harm anxiety, insomnia, seizure disorders - ANSWER benzodiazepine principal indications are daytime sedation; anterograde amnesia - ANSWER benzodiazepines adverse effects IV - ANSWER benzodiazepines are classified as Schedule panic disorder, GAD - ANSWER benzodiazepines are primarily for which two anxiety d/o's GABA - ANSWER benzodiazepines produce their actions by enhancing the effects of _____, the principal inhibitory neurotransmitter in the CNS eszopiclone (Lunesta) - ANSWER benzodiazepines-like controlled substace approved for long-term use in insomnia a component of REMS - ANSWER black box warnings methadone, tramadol, buprenorphine (suboxone) - ANSWER bridging agents commonly abused subutex or suboxone SL - ANSWER buprenorphine formulations used in management of opioid addiction increase cardiac work - ANSWER butorphanol (stadol) and nalbuphne (nubain) are contraind. In MI as they 21 - ANSWER butrans transdermal sites must be rotated. No site may be reused within ___ days frequently undertreated, able to be mitigated in 90% of cases with proper dosing/drug therapy (consider adjuvants) - ANSWER cancer pain ORT (opioid risk tool); SOAPP (screener and opioid assessment for patients with pain); DIRE (diagnois, intractability, risk, and efficacy score) - ANSWER chronic opioid therapy candidates can be identified with 50-70% of the time - ANSWER chronic opioid therapy fails issuance & filling of prescriptions - ANSWER code of fed regulations, title 21, section 1306 governs II, V - ANSWER codeine by itself is a schedule ___ CS. In cough meds, it's often schedule ___ adjuvant analgesics - ANSWER complement effects of opioids (in combo with, not in substitution of) establishes regulations for controlled substances for manufacturers, prescribers, pharmacists, and distributors - ANSWER Comprehensive Drug Abuse Prevention and Control Act (1970) .